AlphaYouJH
Congress trade
Sen. John Hoeven (R-ND) sold $50K-$100K of Merck & Co., Inc. (MRK) stock
John Hoeven, U.S. Senator (R-ND), disclosed a sale of Merck & Co., Inc. (MRK) stock worth $50K-$100K in a STOCK Act filing on Jan 25, 2017.
The trade was disclosed on Jan 25, 2017.
MRK has moved +147.6% since the trade date, from $58.28 to $144.30 (Oct 2, 2026 close).
- Traded
- Jan 25, 2017
- Disclosed
- Jan 25, 2017
- Filing delay
- 0 days
- Price since
- +147.6%
- Source
- STOCK Act disclosure
Other trades in this disclosure (14)
- SellABBV$100K-$250KJan 25, 2017
- BuyCSCO$100K-$250KJan 25, 2017
- SellJNJ$100K-$250KJan 25, 2017
- BuyKO$100K-$250KJan 25, 2017
- BuyPEP$100K-$250KJan 25, 2017
- BuyPG$100K-$250KJan 25, 2017
- SellAMGN$50K-$100KJan 25, 2017
- SellBMY$50K-$100KJan 25, 2017
- BuyINTC$50K-$100KJan 25, 2017
- SellPFE$50K-$100KJan 25, 2017
- BuyT$50K-$100KJan 25, 2017
- BuyVFC$50K-$100KJan 25, 2017
- BuyVZ$50K-$100KJan 25, 2017
- BuyWTW$50K-$100KJan 25, 2017
More MRK insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.